J Immunother Cancer
Dr. Jason J. Luke, MD
- Medicare services, 2024
- 154
- Medicare patients, 2024
- 92
- Part D claims, 2024
- 37
- Publications
- 195
- Clinical trials
- 17
- Practice address
- 300 Halket St, Pittsburgh, PA 15213
- Practice phone
- Call (412) 432-5500
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
UPMC Magee-Womens Hospital
Pittsburgh, Pennsylvania
Find Dr. Luke's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Jason J. Luke is a hematologist and oncologist in Pittsburgh, Pennsylvania
Dr. Luke practices at UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania.
Dr. Luke's NPI, 1093989196, was assigned on April 18, 2008. Dr. Luke holds Pennsylvania license 33440115.
- NPI
- 1093989196NPI Registry (opens in a new tab)
- NPI enumeration date
- April 18, 2008
- NPI status
- Active
- Practice phone
- (412) 432-5500
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 46
- Medical school graduation
- 2006
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Jason J. Luke practices at UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania
Dr. Luke's primary practice is UPMC Magee-Womens Hospital, at 300 Halket St, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 432-5500.
- UPMC Magee-Womens Hospital300 Halket St, Pittsburgh, PA 15213 · Allegheny CountyPhone(412) 432-5500
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Jason J. Luke is affiliated with 1 site of care and 2 medical groups
Dr. Luke's primary practice is UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Luke to 1 more medical group, named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Jason J. Luke's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Luke practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| UPMC Magee-Womens Hospital | Available with a free account |
| +1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Jason J. Luke is one of 645 hematologists and oncologists in Pennsylvania
Hematology and oncology is Dr. Luke's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Luke is board certified in medical oncology by the American Board of Internal Medicine. Dr. Luke is licensed in Pennsylvania.
Specialties and state licenses
- Hematology and oncology, PennsylvaniaPrimary
Hematologists and oncologists near Dr. Luke
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Jason J. Luke billed Medicare for 154 services in 2024
CMS data shows 154 Medicare services from Dr. Luke across 3 procedure codes in 2024, for 92 Medicare patients. Medicare paid $15,076 for them.
Dr. Luke's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 2112024: 15427%
Where Dr. Luke's Medicare services took place, 2024
- In an office12782%
- In a facility2718%
Dr. Luke compared with the Pennsylvania median for hematologists and oncologists, 2024
- Dr. Luke
- Pennsylvania median
- Medicare services
- 154vs 65476% below
- Medicare patients
- 92vs 22759% below
- Part D claims
- 17vs 39396% below
Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.
Dr. Luke's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Luke?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Luke and other hematologists and oncologists in Pennsylvania.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Jason J. Luke treated 92 Medicare patients in 2024, average age 71
CMS counts 92 Medicare patients who saw Dr. Luke in 2024. The largest group is 65 to 74, with 53 patients. 59% of them have high blood pressure, and 57% have high cholesterol. Their average risk score is 3.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Luke's median patient age at 71, with 49% women.
Dr. Luke's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Luke's Medicare patients by sex, 2024
- Women3437%
- Men5863%
Chronic conditions among Dr. Luke's Medicare patients, 2024
- High blood pressure59%
- High cholesterol57%
- Cancer49%
- Arthritis41%
- Ischemic heart disease39%
- Mood disorders28%
- Anxiety27%
- Depression26%
Share of Medicare patients with each condition. A patient can have several.
Dr. Luke's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women49%
- Men49%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Jason J. Luke wrote 37 Medicare Part D claims in 2024
In 2024, Dr. Luke wrote 37 Medicare Part D claims for 16 patients. 100% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $132 in total drug cost. In 2017, CMS named 28 claims across 2 drugs.
Dr. Luke's most prescribed drugs by claims, 2019
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2017 to 2019
- 2017
- 2019
- Claims for drugs CMS names
- 2017: 282019: 1739%
Drugs named by CMS: 1 in 2019, 2 in 2017.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Jason J. Luke scored 81 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Luke for performance year 2024, reported as part of a group.
Dr. Luke's MIPS scores, performance year 2024
- 81of 100Final score
- 61.9of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 75of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Jason J. Luke has 195 publications on record
Dmand AI links 195 papers to Dr. Luke, published from 2011 to 2025. 2024 was the busiest year, with 20. The most frequent topics are Melanoma, Immunotherapy and Skin Neoplasms. Dr. Luke has published most often in Clin Cancer Res. Dr. Luke's most frequent co-authors are Thomas F. Gajewski, Patrick Alexander Ott, MD and Steven J. Chmura.
Dr. Luke's papers by year, 2016 to 2025
Topics Dr. Luke writes about most
- Melanoma
- Immunotherapy
- Skin Neoplasms
- Antibodies, Monoclonal, Humanized
- Immune Checkpoint Inhibitors
- Antineoplastic Combined Chemotherapy Protocols
- Tumor Microenvironment
- Ipilimumab
Dr. Luke's most frequent co-authors
- Thomas F. Gajewski20 shared papers
- Patrick Alexander Ott, MD16 shared papers
- Steven J. Chmura14 shared papers
Recent publications by Dr. Luke
J Immunother Cancer
See who Dr. Luke researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Luke works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Jason J. Luke has worked on 17 clinical trials
Dmand AI links Dr. Luke to 17 clinical trials, 4 of them phase 2 studies. 10 are still active or recruiting. Conditions studied include Melanoma, Nevi and Melanomas and Carcinoma, Renal Cell. Bristol-Myers Squibb sponsors the most, 3. Open Payments lists research payments to Dr. Luke that name 10 trials.
Clinical trials with Dr. Luke by phase
- 2Phase 1: 2 trials
- 1Phase 1/2: 1 trial
- 4Phase 2: 4 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Luke's trials
- Melanoma
- Nevi and Melanomas
- Carcinoma, Renal Cell
- Squamous Cell Carcinoma of Head and Neck
- Carcinoma, Merkel Cell
Investigators on the most trials with Dr. Luke
- Jose Lutzky, MD5 shared trials
- Sandip Pravin Patel, MD4 shared trials
- Andrew Poklepovic, MD4 shared trials
Recent clinical trials with Dr. Luke
Phase I Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors (opens in a new tab)
An Open-Label, Multicenter, Phase 1B/2 Study of RP1 in Solid Organ and Hematopoietic Cell Transplant Recipients With Advanced Cutaneous Malignancies (opens in a new tab)
A Phase II Randomized, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Compared With Investigator Choice in HLA-A*0201 Positive Patients With Previously Untreated Advanced Uveal Melanoma (opens in a new tab)
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Jason J. Luke received $451,592 in industry payments from 2016 to 2025
CMS Open Payments shows 429 general payments to Dr. Luke from 30 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 71% of the total. Merck Sharp & Dohme Corporation paid the most, $123,481. It also lists 26 research payments totaling $15,281 from 2016 to 2025, naming 10 clinical trials.
General payments to Dr. Luke by program year, 2016 to 2025
General payments to Dr. Luke by kind, 2016 to 2025
- Consulting fees$321,24871%
- Travel and lodging$81,92618%
- Speaker and faculty fees$25,4746%
- Food and beverage$8,0592%
- Other$13,9533%
Companies that paid Dr. Luke the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Jason J. Luke is board certified in medical oncology
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Sources for Dr. Jason J. Luke's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Jason J. Luke
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Jason J. Luke's NPI number?
Dr. Jason J. Luke's NPI number is 1093989196. It was assigned on April 18, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Jason J. Luke?
Dr. Jason J. Luke is a hematologist and oncologist in Pittsburgh, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Jason J. Luke practice?
Dr. Luke practices at 300 Halket St, Pittsburgh, PA 15213. Dr. Luke's primary practice is UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania. Dmand AI also links Dr. Luke to 1 medical group.
What is Dr. Jason J. Luke's office phone number?
The practice phone on file for Dr. Luke is (412) 432-5500.
What is Dr. Jason J. Luke's medical license number?
Dr. Luke holds Pennsylvania license 33440115.
What medical group is Dr. Jason J. Luke part of?
Dr. Luke is linked to University of Pittsburgh Physicians, Department of Radiology. Dmand AI links Dr. Luke to 1 more medical group.
Does Dr. Jason J. Luke accept Medicare?
Yes. CMS data shows Dr. Luke billed Medicare for 154 services in 2024.
What is Dr. Jason J. Luke's MIPS score?
Dr. Luke's MIPS final score for performance year 2024 is 81 out of 100, reported as part of a group.
How many Medicare patients does Dr. Jason J. Luke see?
CMS counts 92 Medicare patients who saw Dr. Luke in 2024, with an average age of 71.
Is Dr. Jason J. Luke board certified?
Yes. Dr. Luke is board certified in medical oncology by the American Board of Internal Medicine.
Show 6 more questionsShow fewer questions
What services does Dr. Jason J. Luke bill to Medicare?
In 2024, Dr. Luke's most billed Medicare services were office visit, established patient (99215), hospital inpatient care (99232) and office visit, new patient (99205).
What drugs does Dr. Jason J. Luke prescribe most?
In 2019 Medicare Part D data, Dr. Luke's most prescribed drugs by claims were Levothyroxine Sodium.
Has Dr. Jason J. Luke received payments from drug or device companies?
CMS Open Payments shows $451,592 in general payments to Dr. Luke from 30 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. Jason J. Luke been practicing?
Dr. Luke graduated from medical school in 2006, 20 years ago.
Does Dr. Jason J. Luke do research?
Dmand AI links 195 publications to Dr. Luke, published from 2011 to 2025. Dr. Luke has worked on 17 clinical trials.
Who does Dr. Jason J. Luke publish with?
Dr. Luke's most frequent co-authors are Thomas F. Gajewski (20 shared papers), Patrick Alexander Ott, MD (16 shared papers) and Steven J. Chmura (14 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card